Prediction and Prevention of Preeclampsia

REFERENCES

• Vigil-De Gracia P, Montufar-Rueda C, Ruiz J. Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks’ gestation. Eur J Obstet Gynecol Reprod Biol 2003; 107: 24–27
   PubMed Web of Science ®Google Scholar
• Vigil-De Gracia P, Lasso M, Ruiz E, Vega-Malek J, Tem de Mena F, Lopez J. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol 2006; 128: 157–162
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kucferminc M. Preeclampsia. Lancet 2005; 365: 785–799
   PubMed Web of Science ®Google Scholar
• National high blood pressure education program working group on high blood pressure in pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1–S22
   PubMed Web of Science ®Google Scholar
• Dekker G, Sibai B. Primary, secondary and tertiary prevention of preeclampsia. Lancet 2001; 357: 209–215
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening test for preeclampsia. Obstet Gynecol 2004; 104: 1367–1391
   PubMed Web of Science ®Google Scholar
• Farag K, Hassan I, Ledger W. Prediction of preeclampsia: can it be achieved?. Obstet Gynecol Surv 2004; 59: 464–482
   PubMed Web of Science ®Google Scholar
• Helewa M, Burrow R, Smith J, Williams K, Brain P, Rabkin S. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. Can Med Assoc J 1997; 157: 715–725
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologist. Diagnosis and management of preeclampsia and eclampsia. Practice Bulletin. Number 33. Obstet Gynecol 2002; 99: 159–167
   Google Scholar
• Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007; 197: 35.e1–35.e7
   PubMed Web of Science ®Google Scholar
• Levine R, Lam C, Qian C, Yu K, Maynard S, Sachs B, et al. Soluble endoglin, a novel circulating anti-angiogenic factor in preeclampsia. N Engl J Med 2006; 355: 992–1005
   PubMed Web of Science ®Google Scholar
• Salahuddin S, Lee Y, Vadnais M, Sachs B, Karumanchi A, Lim K. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynecol 2007; 197: 28.e1–28.e6
   Web of Science ®Google Scholar
• Levine R, Maynard S, Qian C, Lim K, England L, Yu K, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672–683
   PubMed Web of Science ®Google Scholar
• Thadhani R, Mutter W, Wolf M, Levine R, Taylor R, Sukhatme V, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770–775
   PubMed Web of Science ®Google Scholar
• Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y. Circulating angiogenic factors in preeclampsia, gestational proteinuria and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol 2006; 194: 551–556
   PubMed Web of Science ®Google Scholar
• Crispi F, Domínguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006; 195: 201–207
   PubMed Web of Science ®Google Scholar
• Vatten L, Eskild A, Nilsen T, Jeansson S, Jenum P, Staff A. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 2007; 196: 239.e1–239.e6
   PubMed Web of Science ®Google Scholar
• Chappell L, Seed P, Briley A, Kelly F, Hunt B, Charnock-Jones D, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127–136
   PubMed Web of Science ®Google Scholar
• Aquilina J, Thompson O, Thilaganathan B, Harrington K. Improved early prediction of preeclampsia by combining second trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol 2001; 17: 477–484
   PubMed Web of Science ®Google Scholar
• Duley L, Meher S, Abalos E. Management of preeclampsia. BMJ 2006; 332: 463–468
   PubMed Web of Science ®Google Scholar
• Sibai B. Biomarkers for hypertension-preeclampsia: are we close yet?. Am J Obstet Gynecol 2007; 197: 1–2
   Google Scholar
• Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005; 330: 576–580
   PubMed Web of Science ®Google Scholar
• Meher S, Abalos E, Carroli G. Bed rest with or without hospitalization for hypertension during pregnancy (Cochrane Review). The Cochrane Library, Issue 1. Update Software, Oxford 2006
   Google Scholar
• Meher S, Duley L. Exercise or other physical activity for preventing preeclampsia and its complications (Cochrane Review). The Cochrane Library, Issue 2. Update Software, Oxford 2006
   Google Scholar
• Hofmeyr G, Atallah A, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Cochrane Review). The Cochrane Library, Issue 3. Update Software, Oxford 2006
   Google Scholar
• Levine R, Hauth J, Curet L. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337: 69–76
   PubMed Web of Science ®Google Scholar
• Villar J, Andel-Aleem H, Merialdi M, Mathai M, Ali M, Zavaleta N, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006; 194: 639–649
   PubMed Web of Science ®Google Scholar
• Hofmeyr G, Duley L, Atallah A. Dietary calcium supplementation for prevention of preeclampsia and related problems: a systematic review and commentary. Br J Obstet Gynecol 2007; 114: 933–943
   Google Scholar
• Rumbold A, Crowther C, Haslam R, Dekker G, Robinson J. Vitamins C and E and the risks of preeclampsia and perinatal complications. ACTS Study Group. N Engl J Med 2006; 354: 1796–1806
   PubMed Web of Science ®Google Scholar
• Rumbold A, Duley L, Crowther C, Haslam R. Antioxidants for preventing preeclampsia (Cochrane Review). The Cochrane Library, Issue 1. Update Software, Oxford 2006
   Google Scholar
• Poston L, Briley A, Seed P, Kelly F, Shennan A. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomized placebo controlled trial. Lancet 2006; 367: 1145–1154
   PubMed Web of Science ®Google Scholar
• Polyzos N, Mauri D, Tsappi M, Tzioras S, Kamposioras K, Cotinovis I, et al. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 2007; 62: 202–206
   PubMed Web of Science ®Google Scholar
• Rouse D. Vitamins C and E and the risks of preeclampsia and perinatal complications. Obstet Gynecol Surv 2006; 61: 619–620
   Google Scholar
• Spinnato J, Livinston J. Prevention of preeclampsia with antioxidants: evidence from randomized trials. Clin Obstet Gynecol 2005; 48: 416–429
   PubMed Web of Science ®Google Scholar
• Villar J, Abalos E, Nardin J, Merialdi M, Carroli G. Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol 2004; 24: 607–615
   PubMed Web of Science ®Google Scholar
• Villar J, Merialdi M, Metin-Gülmezoglu A, Abalos E, Carroli G, Kulier R, et al. Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: an overview of randomized controlled trials. J Nutr 2003; 133: 1606S–1625S
   PubMed Web of Science ®Google Scholar
• Olsen S, Secher N, Tabor A, Weber T, Walter J, Gluud C. Randomized clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. Br J Obstet Gynecol 2000; 107: 382–395
   Google Scholar
• Duley L, Henderson-Smart D. Reduced salt intake compared to normal dietary salt or high intake in pregnancy (Cochrane Review). The Cochrane Library, Issue 1. Update Software, Oxford 2006
   Google Scholar
• Kramer M, Kakuma R. Energy and protein intake in pregnancy (Cochrane Review). The Cochrane Library, Issue 3. Update Software, Oxford 2007
   Google Scholar
• Frederick I, Willimas M, Dashow E, Kestin M, Zhang C, Leisenring W. Dietary fiber, potassium magnesium and calcium in relation to the risk of preeclampsia. J Reprod Med 2005; 50: 332–344
   PubMed Web of Science ®Google Scholar
• Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan K. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003; 101: 1319–1332
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet agents for preventing preeclampsia and its complications. (Cochrane Review). The Cochrane Library, Issue 1. Update Software, Oxford 2006
   Google Scholar
• Ruano R, Fontes R, Zugaib M. Prevention of preeclampsia with low dose aspirin: a systematic review and meta-analysis of the main randomized controlled trials. Clinics 2005; 60: 407–414
   PubMedGoogle Scholar
• Askie L, Duley L, Henderson-Smart D, Steward L, on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791–1798
   PubMed Web of Science ®Google Scholar
• Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias (Cochrane Review). The Cochrane Library, Issue 1. Update Software, Oxford 2006
   Google Scholar
• Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchioni M, et al. Low molecular weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensine converting enzyme DD women. Hypertension 2005; 45: 86–91
   PubMed Web of Science ®Google Scholar
• Rouse D. Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Obstet Gynecol Surv 2007; 62: 697–699
   Google Scholar